Enantiomeric separation of fluoxetine and norfluoxetine in plasma and serum samples with high detection sensitivity capillary electrophoresis
- 1 November 1999
- journal article
- research article
- Published by Wiley in Electrophoresis
- Vol. 20 (17) , 3432-3438
- https://doi.org/10.1002/(sici)1522-2683(19991101)20:17<3432::aid-elps3432>3.0.co;2-8
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Determination of fluoxetine and norfluoxetine in human plasma by high-pressure liquid chromatography with fluorescence detectionJournal of Pharmaceutical and Biomedical Analysis, 1998
- Issues in Methodology and Applications for Therapeutic Drug Monitoring of Fluoxetine and Norfluoxetine EnantiomersTherapeutic Drug Monitoring, 1998
- Quantification of fluoxetine and norfluoxetine serum levels by reversed-phase high-performance liquid chromatography with ultraviolet detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1997
- Analytical methods for the quantitative determination of selective serotonin reuptake inhibitors for therapeutic drug monitoring purposes in patientsJournal of Chromatography B: Biomedical Sciences and Applications, 1996
- Prozac (fluoxetine, lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: Twenty years since its first publicationLife Sciences, 1995
- Determination of fluoxetine and norfluoxetine in human plasma by capillary gas chromatography with electron-capture detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1993
- Analysis of the Enantiomers of Fluoxetine and Norfluoxetine in Plasma and Tissue Using Chiral Derivatization and Normal-Phase Liquid ChromatographyJournal of Liquid Chromatography, 1992
- Determination of Fluoxetine and Norfluoxetine in Serum by Liquid Chromatography with Fluorescence DetectionJournal of Liquid Chromatography, 1990
- FluoxetineAnalytical Profiles of Drug Substances, 1990
- Serum Fluoxetine and Norfluoxetine Concentrations and Antidepressant ResponseTherapeutic Drug Monitoring, 1989